CIK 0000320017
- Non-accelerated filer
- Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222343568
- Phone
- +1 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-02 | GREENACRE MARTYN D Director | Grant or award | +10,000 | 88,531 | ||
| 2015-01-02 | GREENACRE MARTYN D Director | Grant or award | +14,000 | 78,531 | ||
| 2014-01-02 | GREENACRE MARTYN D Director | Grant or award | +14,000 | 64,531 | ||
| 2013-01-04 | GREENACRE MARTYN D Director | Grant or award | +120,000 | 505,306 | ||
| 2012-06-29 | GREENACRE MARTYN D Director | Grant or award | +15,306 | 385,306 | ||
| 2012-05-11 | GREENACRE MARTYN D Director | Purchase | +250,000 | 370,000 | ||
| 2012-05-11 | GREENACRE MARTYN D Director | Purchase · Warrant (Right to Buy) | +250,000 | 250,000 |
Page 1 of 1 · 7 trades